Effect of Ruxolitinib Therapy on Myelofibrosis-Related Symptoms and Other Patient-Reported Outcomes in COMFORT-I: A Randomized, Double-Blind, Placebo-Controlled Trial

PURPOSE: To assess the effects of ruxolitinib on symptom burden and quality of life (QoL) and to evaluate the ability of the modified Myelofibrosis Symptom Assessment Form (MFSAF) v2.0 to measure meaningful changes in myelofibrosis-related symptoms in patients with myelofibrosis. PATIENTS AND METHOD...

詳細記述

保存先:
書誌詳細
出版年:J Clin Oncol
主要な著者: Mesa, Ruben A., Gotlib, Jason, Gupta, Vikas, Catalano, John V., Deininger, Michael W., Shields, Alan L., Miller, Carole B., Silver, Richard T., Talpaz, Moshe, Winton, Elliott F., Harvey, Jimmie H., Hare, Thomas, Erickson-Viitanen, Susan, Sun, William, Sandor, Victor, Levy, Richard S., Kantarjian, Hagop M., Verstovsek, Srdan
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Clinical Oncology 2013
主題:
ORIGINAL REPORTS
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4979167/
https://ncbi.nlm.nih.gov/pubmed/23423753
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2012.44.4489
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料